Intravenous iron isomaltoside 1000 (Monofer(®)) reduces postoperative anaemia in preoperatively non-anaemic patients undergoing elective or subacute coronary artery bypass graft, valve replacement or a combination thereof: the PROTECT trial
Johansson PI, Rasmussen AS, Thomsen LL
Vox Sang 2015;109:257-266.
Review by P. Van der Linden
A randomized, open-label trial of iron isomaltoside 1000 (Monofer®) compared with iron sucrose (Venofer®) as maintenance therapy in haemodialysis patients.
Bhandari S, Kalra PA, Kothari J, et al.
Nephrol Dial Transplant 2015;30:1577-1589.
Review by M. Muñoz
Prevalence of heavy menstrual bleeding and experiences of affected women in a European patient survey.
Fraser IS, Mansour D, Breymann C, Hoffman C, Mezzacasa A, Petraglia F
Int J Gynaecol Obstet 2015;128:196-200.
Review by L. T. Goodnough
Patient blood management in cardiac surgery results in fewer transfusions and better outcome.
Gross I, Seifert B, Hofmann A, Spahn DR
Transfusion 2015;55:1075-1081.
Review by J.-F. Hardy
Anemia predicts thromboembolic events, bleeding complications and mortality in patients with atrial fibrillation: insights from the RE-LY trial.
Westenbrink BD, Alings M, Connolly SJ, et al.
J Thromb Haemost 2015;13:699-707.
Review by D. Faraoni
Effect of oral liposomal iron versus intravenous iron for treatment of iron deficiency anaemia in CKD patients: a randomized trial.
Pisani A, Riccio E, Sabbatini M, Andreucci M, Del Rio A, Visciano B
Nephrol Dial Transplant 2015;30:645-652.
Review by M. Muñoz
Beneficial effects of long-term intravenous iron therapy with ferric carboxymaltose in patients with symptomatic heart failure and iron deficiency.
Ponikowski P, van Veldhuisen DJ, Comin-Colet J, et al.
Eur Heart J 2015;36:657-668.
Review by L. T. Goodnough
PREPARE: the prevalence of perioperative anaemia and need for patient blood management in elective orthopaedic surgery: A multicentre, observational study.
Lasocki S, Krauspe R, von Heymann C, Mezzacasa A, Chainey S, Spahn DR
Eur J Anaesthesiol 2015;32:160-167.
Review by E. Bisbe
Data from the Dialysis Outcomes and Practice Patterns Study validate an association between high intravenous iron doses and mortality.
Bailie GR, Larkina M, Goodkin DA, et al.
Kidney Int 2015;87:162-168.
Review by M. Auerbach
Practice guidelines for perioperative blood management: an updated report by the American Society of Anesthesiologists Task Force on Perioperative Blood Management.
Anesthesiology 2015;122:241-275.
Review by J.-F. Hardy
Preoperative hematocrit as a predictor of perioperative morbidities following nonemergent coronary artery bypass surgery.
Spiegelstein D, Holmes SD, Pritchard G, Halpin L, Ad N
J Card Surg 2015;30:20-26.
Review by P. Van der Linden
Effect of the antihepcidin Spiegelmer lexaptepid on inflammation-induced decrease in serum iron in humans.
van Eijk LT, John AS, Schwoebel F, et al.
Blood 2014;124:2643-2646.
Review by L. T. Goodnough
Intravenous iron alone resolves anemia in patients with functional iron deficiency and lymphoid malignancies undergoing chemotherapy.
Hedenus M, Karlsson T, Ludwig H, et al.
Med Oncol 2014;31:302.
Review by M. Auerbach
Preoperative anemia increases mortality and postoperative morbidity after cardiac surgery.
Miceli A, Romeo F, Glauber M, de Siena PM, Caputo M, Angelini GD
J Cardiothorac Surg 2014;9:137.
Review by S. Kozek-Langenecker
The feasibility and clinical efficacy of intravenous iron administration for preoperative anaemia in patients with colorectal cancer.
Keeler BD, Simpson JA, Ng S, et al.
Colorectal Dis 2014;16:794-800.
Review by B. Clevenger, T. Richards
MISSION: Providing a multidisciplinary forum for dialogue between haematologists, transfusion medicine specialists, anaesthesiologists, intensive care and emergency physicians, surgeons, perfusionists, nurses, biomedical scientists and other healthcare professionals.